IBOK
SUPN icon

Independence Bank of Kentucky’s Supernus Pharmaceuticals SUPN Stock Holding History

Independence Bank of Kentucky’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-120
Closed -$4K – 452
2022
Q3 		$4K Buy
+120
New +$3.9K ﹤0.01% 386

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Independence Bank of Kentucky's SUPN Position: Q4 2022 in Review

Independence Bank of Kentucky sold out of Supernus Pharmaceuticals (SUPN) in Q4 2022, closing a stake of 120 shares — an estimated $4K sold.

Independence Bank of Kentucky first reported a position in SUPN in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 263 funds tracked by Wall St. Rank hold SUPN as of Q4 2022.

  • Independence Bank of Kentucky reported no remaining Supernus Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Independence Bank of Kentucky sold 120 Supernus Pharmaceuticals shares in Q4 2022, an estimated $4K.
  • Independence Bank of Kentucky first reported a position in Supernus Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • Independence Bank of Kentucky's Supernus Pharmaceuticals position peaked at $4K in Q3 2022.
  • 263 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2022.

Based on Independence Bank of Kentucky's 13F filing for Q4 2022, filed 9 Jan 2023.